SORAFENIB

Trials studying SORAFENIB

• phase2A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinomacompletedn=25
• phase3Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alonecompletedn=459
• phase2Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenibactive not recruitingn=30
• —Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenibactive not recruitingn=453
• phase3A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinomaactive not recruitingn=732
• phase2Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancercompletedn=10
• phase3Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinomaactive not recruitingn=1,324
• phase3A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCCcompletedn=344